Metabolomic profiling and stable isotope labelling of Trichomonas vaginalis and Tritrichomonas foetus reveal major differences in amino acid metabolism including the production of 2-hydroxyisocaproic acid, cystathionine and S-methylcysteine by Westrop, Gareth D. et al.
RESEARCH ARTICLE
Metabolomic profiling and stable isotope
labelling of Trichomonas vaginalis and
Tritrichomonas foetus reveal major differences
in amino acid metabolism including the
production of 2-hydroxyisocaproic acid,
cystathionine and S-methylcysteine
Gareth D. Westrop1*, Lijie Wang1, Gavin J. Blackburn2, Tong Zhang3, Liang Zheng4, David
G. Watson1, Graham H. Coombs1
1 Strathclyde Institute of Pharmacy and Biomedical Science, Strathclyde University, Glasgow, United
Kingdom, 2 Glasgow Polyomics, University of Glasgow, Glasgow, United Kingdom, 3 Institute of Cancer
Sciences, University of Glasgow, Glasgow, United Kingdom, 4 Pediatric Translational Medicine Institute,
Shanghai Children’s Medical Center, Shanghai, China
* gareth.westrop@strath.ac.uk
Abstract
Trichomonas vaginalis and Tritrichomonas foetus are pathogens that parasitise, respec-
tively, human and bovine urogenital tracts causing disease. Using LC-MS, reference meta-
bolomic profiles were obtained for both species and stable isotope labelling with D-[U-13C6]
glucose was used to analyse central carbon metabolism. This facilitated a comparison of
the metabolic pathways of T. vaginalis and T. foetus, extending earlier targeted biochemical
studies. 43 metabolites, whose identities were confirmed by comparison of their retention
times with authentic standards, occurred at more than 3-fold difference in peak intensity
between T. vaginalis and T. foetus. 18 metabolites that were removed from or released into
the medium during growth also showed more than 3-fold difference between the species.
Major differences were observed in cysteine and methionine metabolism in which homocys-
teine, produced as a bi-product of trans-methylation, is catabolised by methionine γ-lyase in
T. vaginalis but converted to cystathionine in T. foetus. Both species synthesise
methylthioadenosine by an unusual mechanism, but it is not used as a substrate for methio-
nine recycling. T. vaginalis also produces and exports high levels of S-methylcysteine,
whereas only negligible levels were found in T. foetus which maintains significantly higher
intracellular levels of cysteine. 13C-labeling confirmed that both cysteine and S-methylcys-
teine are synthesised by T. vaginalis; S-methylcysteine can be generated by recombinant T.
vaginalis cysteine synthase using phosphoserine and methanethiol. T. foetus contained
higher levels of ornithine and citrulline than T. vaginalis and exported increased levels of
putrescine, suggesting greater flux through the arginine dihydrolase pathway. T. vaginalis
produced and exported hydroxy acid derivatives of certain amino acids, particularly 2-
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hydroxyisocaproic acid derived from leucine, whereas negligible levels of these metabolites
occurred in T. foetus.
Introduction
Parabasalids are a large and diverse group of flagellated protozoa that lack mitochondria and
have an anaerobic metabolism involving specialised organelles called hydrogenosomes [1].
These are adapted mitochondria that produce hydrogen as an end product of pyruvate fer-
mentation. These protozoa have other distinctive structural features, including 3–5 flagella, a
complex cytoskeleton and an enlarged golgi apparatus referred to as a parabasal body. The
majority of these organisms are commensals of the enteric tract of animals but the group
includes several pathogens, the most important being Trichomonas vaginalis and Tritrichomo-
nas foetus that infect the urogenital tract of humans and cattle, respectively [2, 3].
T. vaginalis is the causative agent of trichomoniasis, an exceptionally common sexually
transmitted disease of humans. Infection causes inflammation or vaginitis in about 30% of
women and without treatment infection can be long lasting. In men, however, T. vaginalis
infections are self-clearing and generally asymptomatic. Trichomoniasis is a cofactor in the
transmission of HIV [4], the development of prostate cancer [5–7] and in pregnancy is linked
to pre-term delivery and low birth weight [8, 9]. Infections can usually be controlled by
5-nitroimidazoles such as metronidazole, although drug resistance is a problem [10]. Tricho-
moniasis has been identified as a neglected parasitic infection by the CDC (http://www.cdc.
gov/parasites/npi/index.html) and targeted for public health action.
T. foetus infections cause trichomoniasis in cattle where the main symptom is inflammation
of the genital tract. Infection can cause sterility and in some cases involves the placenta, lungs
and lymph nodes of the developing foetus and results in abortion [3]. Although primarily
regarded as a bovine parasite, some strains of T. foetus can infect cats where they colonise
mucosal surface of the gastro-intestinal tract and cause feline bowel disease [11]. Bovine and
feline strains show a high species and organ specificity.
The T. vaginalis genome is exceptionally large and has a highly repetitive structure [12];
65% of the genome consists of transposable elements and many protein coding genes are repli-
cated to form high copy number gene families. A draft genome sequence of T. foetus strain K
was recently published [13], making it possible to determine how closely related these tricho-
monads are genetically. Initial analysis revealed that 72% of ORFs in the T. foetus genome were
similar to T. vaginalis, and 28% were not found in any other organism. In a separate study
application of reduced representation genome sequencing revealed that gene mutations were
shared between metronidazole resistant strains of T. vaginalis and T. foetus suggesting a com-
mon mechanism for development of resistance [14]. It is interesting that T. foetus has an esti-
mated genome size of 161 Mb [13, 15] which is similarly large to the 160 Mb draft genome of
T. vaginalis [12]. It also contains 62% repetitive sequences and many repeatedly duplicated
genes suggesting that the genome of T. foetus evolved by massive expansion as proposed for T.
vaginalis [13, 16]. Thus extreme genome size seems another common feature of T. vaginalis
and T. foetus that distinguishes them from many other parabasalid species.
Similarities and differences between the metabolism of the two species, especially concerning
their anaerobic energy metabolism, are known from various biochemical studies and have been
reviewed extensively [17]. The major end products of glucose metabolism in T. vaginalis are
glycerol, lactate and ethanol in the cytoplasm and H2, CO2 and acetate in the hydrogenosome.
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
PLOS ONE | https://doi.org/10.1371/journal.pone.0189072 December 21, 2017 2 / 34
Alanine is produced from pyruvate as a minor end product but is not excreted. The end prod-
ucts formed in T. foetus are broadly similar but they do not produce lactate with instead succi-
nate representing about 50% of the carbon released as fermentation products. Interesting
differences also occur with the advent of metronidazole resistance, with metabolism shifted to
lactate production in T. vaginalis but to ethanol in T. foetus [17].
A notable species difference is that T. vaginalis produces methanethiol (CH3SH), 2-ketobu-
tyrate and NH3 by catabolism of methionine using methionine γ-lyase (MGL), although bio-
chemical analysis failed to detect this activity in T. foetus or other trichomonad species [18].
The T. vaginalis MGL has a broad specificity and it has been proposed that H2S released from
homocysteine by MGL is used by the cysteine synthase (CS) to produce cysteine from O-phos-
phoserine [19]. Cysteine is the main intracellular thiol as T. vaginalis and T. foetus do not pro-
duce glutathione or have glutathione-dependent enzymes [20].
In general, targeted biochemical analyses such as these have identified and focussed on
pathways that differentiate trichomonad parasites from the mammalian host, with possible
value for chemotherapeutic exploitation [21, 22] and have also highlighted differences between
the species that could be linked to host range and pathogenicity. The advent of metabolomic
techniques allowing non-targeted approaches for comparing the metabolomes of species has
provided new opportunities for comparative analysis of the two trichomonad species. We
recently compared the metabolomes of promastigotes of three Leishmania species and identi-
fied differences in amino acid metabolism that could, if also present in the mammalian form
of the parasites, play crucial roles in determining the variations in infection [23]. We have now
in this study, using the same methodology, compared the metabolites in and released by T.
vaginalis and T. foetus. Samples were analysed by LCMS and metabolites were identified from
their accurate mass, by comparison of their retention times with those of authentic standards,
or by fragmentation analysis. Standard curves were prepared to provide an estimate of the rela-
tive concentrations. Labelling by growth of the parasites in media containing D-[U-13C6] glu-
cose was used to confirm that metabolites were synthesised by the parasites and to compare
the rates of production of intermediates in central carbon metabolism. In addition, a targeted
analysis of T. vaginalis was carried out by comparing extracts of the parasite grown in media
variations known to affect sulphur amino acid metabolism.
Our approach provides new information on the function of metabolic enzymes in T. vagi-
nalis, an organism where methods for transfection and genetic manipulation are difficult and
currently limited [14, 24].
Materials and methods
Trichomonad strains used in this study
The strains used in this study were Trichomonas vaginalis clone G3 and Tritrichomonas foetus
clone F2. T. vaginalis G3 was the strain used for genomic sequencing [12]. T. foetus F2 is a
clonal line originally derived in our laboratory from the Pfizer strain [25].
Culture of T. vaginalis and T. foetus
T. vaginalis and T. foetus cells were maintained in 25 ml of MDM medium in sealed tubes with
little gaseous phase. Cultures were initiated at a concentration of 1 x 105 cells/ml and sub-cul-
tured after 16 hours growth at 37˚C when the cell concentration was 2 to 4 x 106 cells/ml. The
composition of MDM, which contains no added cysteine, was: 20 mg/ml Tripticase™ peptone
(BD), 5 mg/ml maltose, 1 mg/ml ascorbic acid, 1 mg/ml KCl, 1 mg/ml KHCO3, 1 mg/ml
KH2PO4, 0.5 mg/ml K2HPO4, 0.1 mg/ml FeSO4.2H2O, 10% (v/v) heat inactivated Horse
Serum (Thermo Fisher Scientific), pH 6.2–6.3.
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Preparation of extracts for LC-MS
T. vaginalis and T. foetus were grown in the same media under identical conditions. Extracts
were prepared from at least 4 independent cultures (biological replicates). For each replicate,
60 ml MDM in a 25 cm2 tissue culture flask was inoculated with an overnight culture to give a
concentration of 105 cells/ml. The lids were sealed and cultures were incubated in an upright
position, with very little gaseous phase so that the culture rapidly becomes anaerobic. After
growth for 16 hours at 37˚C, 40 ml of the culture was transferred to a 50 ml centrifuge tube
and quenched rapidly to a temperature of 4˚C using a dry-ice ethanol bath, monitoring the
temperature continuously with a digital thermometer.
After centrifugation at 1000 x g for 30 min at 4˚C, the supernatant medium was transferred
to an ice-cold 50 ml centrifuge tube and stored on ice. The cell pellet was resuspended in 40 ml
ice-cold PBS and stored on ice while the cell concentration was determined using a haemocyt-
ometer. After a second centrifugation, the cells were re-suspended to give a concentration of 2
x 107 cells/ml. 1 ml of the suspension was transferred to an ice-cold 1.5 ml microfuge tube and
the cells were pelleted at 2000 x g for 10 min at 4˚C. The pellets were mixed with 0.2 ml of
extraction buffer (chloroform: methanol: water, 1:3:1) and the metabolites were extracted by
shaking at 1000 rpm for 1 h at 4˚C. Extracts were cleared by centrifugation at 21,000 x g for 10
min and 0.2 ml was transferred to a glass HPLC vial with a 0.2 ml insert. A blank was prepared
by adding 0.2 ml of extraction buffer to an empty microfuge tube and treating in the same way
as the samples. Extracts of media samples were prepared by mixing 75 μl of the sample with
0.3 ml of extraction buffer (chloroform:methanol, 1:3), shaking for 1 h at 4˚C and clearing the
extract by centrifugation at 21,000 x g for 10 min at 4˚C. All extracts were stored at -80˚C
before use.
Measurement of the protein content of cell extracts
A replicate sample containing 2 x 107 cells was prepared from each culture as described above.
The washed cell pellet was resuspended in 100 μl of lysis buffer (0.25 M sucrose, 0.25% (v/v)
Triton X-100, 10 μM E64, 1 mM phenanthroline, 20 mM pepstatin A, 5 mM PMSF). Cells
were lysed by aspiration with a pipette and the extract was cleared by centrifugation at 14,000 x
g for 15 min at 4˚C. The protein content was determined using the Bio-Rad protein assay
(Bio-Rad).
13C labelling of T. vaginalis and T. foetus for LC-MS
MDM contains 5 mg/ml maltose as the main carbon source. In a preliminary experiment, we
found that both T. vaginalis and T. foetus grew at similar rate in modified MDM without malt-
ose supplemented with 5 mg/ml glucose. Labelling experiments were carried out using modi-
fied MDM containing 5 mg/ml D-[U-13C6] glucose (CK Isotopes). Cells from an overnight
culture were washed by centrifugation (1000 x g for 10 mins at 4˚C) and resuspension in modi-
fied MDM without glucose. 60 ml of modified MDM containing 5 mg/ml D-[U-13C6] glucose
was inoculated with washed cells to give a concentration of 105 cells/ml. Extracts for LCMS
were prepared after 2 h, 6 h or 16 h growth at 37˚C as described above. The medium contained
no maltose and 100% of the available glucose was labelled.
LC-MS
The LC-MS platform for metabolic profiling consisted of an Accela 600 HPLC system com-
bined with an Exactive (Orbitrap) mass spectrometer from Thermo Fisher Scientific (Bremen,
Germany). Two complementary columns, the zwitterionic ZIC-pHILLIC column (150
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mm × 4.6 mm; 3.5 μm, Merck, Germany) and the reversed phase ACE C18-AR column (150
mm × 4.6 mm; 3.5 μm, Hichrom) were used. With both systems, the injection volume was
10 μl and the flow rate was 0.3 ml/min. The ZIC-pHILLIC column was eluted using a gradient
of mobile phase A, 20 mM ammonium carbonate pH 9.2, and mobile phase B, acetonitrile
(ACN). The concentration of A was increased from 20% to 80% over 30 min and then held at
92% for 5 mins, before equilibrating at 20%. The mobile phases for the reverse phase column
were: A, 0.1% (v/v) formic acid in H20; B, 0.1% (v/v) formic acid in ACN. Mobile phase A was
decreased from 95% to 10% over 30 min and held at 10% for 5 min. The settings for the mass
spectrometer were as described previously [23].
Data processing
Raw data files of metabolite standard solutions were processed using ToxID 2.1 (Thermo
Fisher Scientific Inc., Hemel Hempstead, UK) as described previously [23]. After visual evalua-
tion of the extracted ion chromatograms, the retention times of the standards were used to cal-
ibrate IDEOM v19 [26]. Raw files of sample metabolites were processed as described
previously [23]. Briefly, the data files were converted to mzXML open format using msConvert
(ProteoWizard). Chromatograms were extracted using XCMS and stored in PeakML before
aligning replicate peaks and combining them using mzMatch.R. After noise filtering and gap
filling a CSV file was generated and imported into IDEOM v19 for metabolite identification
based on accurate mass (± 3 ppm) and retention time prediction. The lipids and peptides were
excluded from the lists of putatively identified metabolites in the biological samples.
Analysis of 13C labelled metabolites
Raw data from LCMS of the 13C-labelled extracts was processed to generate a combined
PeakML file as described above. This was further analysed using mzMatch-ISO in R [27, 28],
generating a.pdf file containing chromatograms used to check peak-shape and retention time
and a tab-delineated file detailing peak height for each isopotologue which was used to calcu-
late percentage labelling.
Metabolite identification
The identities of a subset of metabolites were confirmed by accurate mass and in addition
either by matching the sample retention time to that of an authentic standard (± 0.2 min) or
by obtaining MS2 spectra as described previously [23]. The confirmed metabolites correspond
to the metabolic standards initiative (MSI) level 1. Metabolites putatively identified by accurate
mass and predicted retention time correspond to MSI level 2.
Assay for cysteine synthase and S-methylcysteine synthase activity
Recombinant T. vaginalis cysteine synthase (CS) and T. vaginalis methionine γ-lyase type 1
(MGL1) were expressed and purified as described previously [19, 29]. Specific activities using
standard assays were 13 μmol/mg CS (with 3 mM sodium sulfide (Na2S) and 50 mM O-phos-
phoserine (OPS)) and 8 μmol/min/mg MGL (with 3 mM homocysteine). The activity of CS in
the production of S-methylcysteine (SMC) from -OPS and sodium methanethiolate (CH3S.
Na) was measured in a coupled assay using MGL1 and lactate dehydrogenase (LDH). The
reaction was carried out in 1 ml of 200 mM potassium phosphate pH 7.8, 10 mM OPS, 3 mM
CH3S.Na, 5 mM 2-ketoglutarate, 0.2 mM NADH, 60 μg MGL1, 25 units LDH (Sigma) and
2 μg CS. The CS activity was measured under the same conditions by substituting the CH3S.
Na with 3 mM Na2S. Kinetic analysis of the SMC synthase and CS activities was carried out
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with a fixed (saturating) concentration of the first substrate and at least 6 different concentra-
tions of the second. Values for Km and Vmax were determined by plotting the data using GraFit
5 (Erithacus Software).
Identification of genes for metabolic enzymes in the draft genome
nucleotide sequence of T. foetus
Putative genes for selected metabolic enzymes were identified by tblastn search of the whole
genome shotgun contigs (wgs) database, BioProject ID 345179. Model protein sequences were
obtained from TrichDB (trichdb.org) for T. vaginalis or KEGG (www.genome.jp/kegg) for
other organisms.
Results
We compared the untargeted metabolomic profiles of T. vaginalis and T. foetus to obtain
insights into differences in their biochemical pathways and the levels of variances of metabo-
lites that could be associated with differences in host range and pathogenicity. Cell extracts
were first analysed by LC-MS using a ZIC-pHILLIC column for the separation step and condi-
tions previously optimised to identify the widest possible range of polar metabolites [23]. Raw
data was processed and metabolites identified using IDEOM v19 [26] calibrated with retention
times obtained for 240 authentic standards. The data was screened to remove lipids and pep-
tides which cannot be accurately identified under the conditions used. From the pHILLIC col-
umn, 86 metabolites were identified by accurate mass and confirmed by comparison of their
retention times with those of authentic standards (difference 0.2 minutes). The identities of
another 5 metabolites were confirmed by MS2 analysis. The same extracts were then analysed
using a reverse phase (C18AR) column for LC-MS that provided complementary coverage,
allowing confirmed identification of 19 additional metabolites including polyamines. The 110
confirmed metabolites were mapped to metabolic pathways for amino acids, carbohydrates,
nucleotides, vitamins and co-factors and energy metabolism with 9 metabolites belonging to
no known pathway (S1 Table). 18 of these metabolites were found only in cell extracts and 3
metabolites were specific to the media. An additional 225 metabolites from cell extracts were
putatively identified on the basis of accurate mass and predicted retention time in IDEOM v19
(S2 Table). 287 metabolites were putatively identified in medium samples (S3 Table).
Overall comparison of T. vaginalis and T. foetus cell extracts
The mean peak intensity values indicating the relative levels of metabolites in the different spe-
cies were calculated from results for at least 4 biological replicates. As described previously,
our method for extract preparation was optimised so that the LC-MS data did not need nor-
malising (23). In addition, we focused mainly on large differences in mean peak intensity
(> 3-fold). 43 out of 107 confirmed metabolites from cell extracts of T. vaginalis and T. foetus
showed greater than 3-fold differences in peak intensity between species (Table 1). The pattern
observed with the different metabolites showing either relatively high or low levels in the two
species could not be the result of differences in cell volume. For example T. vaginalis has
88-fold higher levels of D-gluconic acid but 20-fold lower level of succinic acid compared with
T.foetus. In addition, the protein content of T. vaginalis cell extracts, an indication of cell vol-
ume, was found to be only 1.5-fold higher than T. foetus. The protein content for 2 x 107 cells
was 540 ± 90 μg for T. vaginalis and 360 ± 50 μg for T. foetus. This supports our choice of a
three-fold change in peak intensity as the threshold for a clear difference between the species.
Differences were observed in the levels of nucleotide and amino sugars, hydroxy acid deriva-
tives of amino acids, carboxylic acids, metabolites belonging to pathways for cysteine and
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
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Table 1. Metabolites from cell extracts showing more than 3-fold difference between species.
Metabolite Formula T. vaginalis Mean PI T. foetus Mean PI Tvag/Tfoe Pathway
Malonate C3H4O4 1.15E+05 3.04E+04 3.79 Pyrimidine/ β-alanine
2-Hydroxybutanoate C4H8O3 3.97E+06 5.69E+04 69.84 Propanoate
Uracil C4H4N2O2 6.29E+05 2.52E+06 0.25 Pyrimidine
Creatinine C4H7N3O 1.48E+06 2.91E+05 5.07 Arginine and proline
Succinate C4H6O4 3.48E+06 6.41E+07 0.05 Glucose metabolism
5-Oxoproline C5H7NO3 6.30E+07 1.45E+07 4.35 Arginine and proline
L-Pipecolate C6H11NO2 7.63E+07 8.90E+06 8.57 Lysine
Creatine C4H9N3O2 8.18E+05 1.18E+05 6.93 Arginine and Proline
HICA C6H12O3 1.82E+07 2.49E+06 7.3 Leucine
L-Ornithine C5H12N2O2 1.45E+05 4.26E+05 0.34 Arginine and Proline
Malate C4H6O5 8.58E+06 2.08E+06 4.12 Glucose metabolism
SMC C4H9NO2S 1.15E+06 5.43E+03 212.62 Unknown
Hypoxanthine C5H4N4O 6.47E+06 9.57E+05 6.76 Purine
Histidinal C6H9N3O 5.05E+05 4.00E+04 12.63 Histidine
4-guanidinobutanoate C5H11N3O2 2.49E+05 4.96E+04 5.03 Arginine and Proline
2-ketoglutarate C5H6O5 5.42E+05 3.75E+06 0.14 Glutamate
L-Lysine C6H14N2O2 1.47E+06 6.02E+06 0.24 Lysine
Imidazolone lactate C6H8N2O3 1.30E+06 1.38E+04 94.1 Histidine
N6-Methyl-L-lysine C7H16N2O2 2.12E+04 2.72E+03 7.79 Lysine
L-Carnitine C7H15NO3 3.03E+04 9.96E+03 3.04 Lysine/ acylcarnitine
Phenyllactate C9H10O3 1.02E+07 9.39E+05 10.9 Phenylalanine
N(pi)-Methyl-L-histidine C7H11N3O2 1.82E+05 4.50E+04 4.04 Histidine
Indole-3-acetate C10H9NO2 7.57E+03 1.98E+03 3.82 Tryptophan
L-Citrulline C6H13N3O3 9.40E+05 5.32E+06 0.18 Arginine
D-Glucosamine C6H13NO5 5.15E+03 1.54E+03 3.34 Amino / Nucleotide sugar
N6-Acetyl-L-lysine C8H16N2O3 2.62E+05 9.68E+05 0.27 Lysine
Carboxyspermidine C8H19N3O2 1.00E+05 1.57E+04 6.41 Arginine and Proline
D-Gluconic acid C6H12O7 1.21E+07 1.37E+05 88.35 Pentose Phosphate
Indolepyruvate C11H9NO3 3.88E+03 1.13E+03 3.42 Tryptophan
O-Acetylcarnitine C9H17NO4 1.11E+05 1.61E+04 6.88 Acylcarnitine
Pantothenate C9H17NO5 4.51E+05 1.33E+05 3.4 Pantothenate
L-Cystathionine C7H14N2O4S 1.19E+04 3.24E+05 0.04 Methionine
L-Cystine C6H12N2O4S2 7.27E+03 1.01E+05 0.07 Cysteine
Cysteine: Homocysteine disulfide C7H14N2O4S2 0.00E+00 1.06E+05 0 Unknown
Thiamin C12H16N4OS 2.92E+05 1.64E+06 0.18 Thiamine
Inosine C10H12N4O5 4.27E+05 8.26E+04 5.17 Purine
Guanosine C10H13N5O5 2.67E+03 2.30E+04 0.12 Purine
N-Acetyl-D-Glucosamine 6-phosphate C8H16NO9P 9.16E+04 3.06E+04 3 Amino / Nucleotide sugar
N-Acetylneuraminate C11H19NO9 8.23E+03 5.49E+04 0.15 Amino / Nucleotide sugar
Sucrose C12H22O11 2.27E+05 3.61E+04 6.28 Carbohydrate
IMP C10H13N4O8P 3.88E+04 7.81E+03 4.97 Purine
SAH C14H20N6O5S 2.78E+04 1.53E+05 0.18 Methionine
UDP-N-acetyl-D-glucosamine C17H27N3O17P2 2.49E+06 6.22E+05 3.99 Amino / Nucleotide sugar
NADP+ C21H28N7O17P3 1.06E+05 4.83E+05 0.22 Nicotinate and Nicotinamide
The table shows mean peak intensities (PI) from LCMS analysis of T. vaginalis and T. foetus cell extracts. Numbers represent the mean of at least four
extracts from independent cultures. Tvag/Tfoe indicates the ratio of the PI values. P-values0.005 (Paired T-Test, assuming equal variance). Except for
malonate, 4-guanidinobutanoate and indole pyruvate where P  0.05. Full details including individual standard deviation and P values are shown in S2
Table.
HICA, 2-hydroxyisocaproate; SAH, S-adenosyl-L-homocysteine; SMC, S-methylcysteine.
https://doi.org/10.1371/journal.pone.0189072.t001
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
PLOS ONE | https://doi.org/10.1371/journal.pone.0189072 December 21, 2017 7 / 34
methionine metabolism, arginine metabolism, lysine metabolism and in the production of
thioethers not previously identified in trichomonads.
Comparison of cell extracts showed that the intracellular amino acid pools of the two spe-
cies were generally similar, however T. foetus cell extracts contained 5-fold higher levels of
lysine whereas T. vaginalis had relatively high levels of the lysine metabolites pipecolate,
N6-methyl-lysine, carnitine and N-acetyl-carnitine (Table 1 and S2 Table). Significantly, our
results show that T. foetus maintains up to 20-fold higher levels of cysteine, detected as cystine
by LCMS following in-situ oxidation. Various aspects of amino acid metabolism were analysed
in more detail and the data are presented in the following sub-sections.
Overall comparison of metabolites in media samples
In order to identify metabolites taken up or exported by the parasites, peak intensity levels in
complete or uninfected media samples were compared with spent media, the supernatant after
cells were removed from cultures by centrifugation (Table 2, S3 Table). 16 confirmed metabo-
lites from T. vaginalis spent media and 6 from T. foetus showed more than 3-fold difference
when compared with complete media. Comparisons of these ratios revealed that for 18 metab-
olites there was greater than 3-fold difference in their rate of uptake or release between the spe-
cies. T. vaginalis takes up higher levels of nucleosides, phosphoserine and
5-methylthioadenosine but releases hydroxy acids and SMC. Succinate is produced and
exported by T. foetus. In addition, T. foetus releases, 2.8 fold higher levels of putrescine, just
outside our 3-fold threshold for a clear difference between species. As expected, spent media
from cultures of both species show an increase in putrescine and a decrease in spermidine lev-
els compared with uninfected medium (Table 2). Trichomonads can synthesise putrescine but
lack S-adenosylmethionine decarboxylase required for conversion to spermidine. They can
obtain spermidine from the growth medium and uptake of spermine is known to be coupled
to export of putrescine by an antiporter [30]. T. vaginalis is distinct from T. foetus in importing
phosphoserine, purines and purine nucleosides, methylthioadenosine and nicotinamide
(Table 2).
Amino acids are metabolised to produce 2-hydroxy acids in T. vaginalis
but not in T. foetus
2-Hydroxy acids, derived from amino acids by deamination and reduction, were detected in
cell extracts of both species, but with markedly higher peak intensities in T. vaginalis. To ana-
lyse the situation in greater depth, the concentrations of the most abundant hydroxy acids
together with their keto acid and amino acid precursors were determined by constructing cali-
bration curves using authentic standards, as described previously [23]. The T. vaginalis extracts
contained 28 nmol/108 cells of 2-hydroxyisocaproic acid (HICA), 7-fold higher than in T. foe-
tus (Table 3). The intracellular pools of the precursors, 2-isocaproic acid and leucine were also
higher in T. vaginalis. Levels of HICA in the spent medium reached 21 μM after growth of T.
vaginalis for 20 h, 55-fold higher than the concentration in the original growth medium,
whereas there was no significant change in the level of HICA in the T. foetus spent medium
(Table 4). Utilisation of leucine by T. vaginalis did not result in a change in the concentration
of leucine in the media samples which was approximately 500 μM (Table 4). Tryptophan and
phenylalanine were metabolised in a similar way with concentrations of indole lactate and phe-
nyl lactate in T. vaginalis extracts of 14.0 and 1.3 nmol/108 cells, respectively (Table 3). These
results show that T. vaginalis can catabolise amino acids to produce 2-hydroxy acids at a
markedly higher rate than T. foetus. Certain amino acids are used preferentially by T. vaginalis
with higher levels of 2-hydroxy acids obtained from leucine and phenylalanine than from
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Table 2. Metabolites taken up or exported into media during growth of T. vaginalis and T. foetus.
Metabolite Formula MDMc Mean
PI
TvagSPT Mean
PI
TfoeSPT Mean
PI
TvagSPT/
MDMc
TfoeSPT/
MDMc
TvagSPT/
TfoeSPT
Putrescine C4H12N2 4.34E+03 7.56E+03 2.08E+04 1.74 4.79 0.36
2-Hydroxybutanoate C4H8O3 1.55E+05 4.94E+06 1.64E+05 31.85 1.06 30.15
Succinate C4H6O4 1.08E+07 1.10E+07 4.35E+07 1.02 4.03 0.25
Nicotinamide C6H6N2O 1.24E+06 4.49E+03 1.12E+06 0.00 0.91 0.00
L-Pipecolate C6H11NO2 1.77E+06 1.87E+07 2.41E+06 10.53 1.36 7.74
HICA C6H12O3 2.10E+05 1.31E+07 2.87E+05 62.44 1.37 45.59
SMC C4H9NO2S 6.65E+03 2.64E+05 6.21E+03 39.70 0.93 42.57
Hypoxanthine C5H4N4O 7.72E+05 8.10E+06 1.01E+06 10.49 1.30 8.04
Ethanolamine
phosphate
C2H8NO4P 7.67E+03 1.05E+04 3.71E+04 1.37 4.84 0.28
Spermidine C7H19N3 2.92E+06 1.90E+05 2.66E+05 0.07 0.09 0.71
Guanine C5H5N5O 1.06E+05 1.54E+04 1.29E+05 0.15 1.21 0.12
Phenyllactate C9H10O3 2.59E+05 7.41E+06 5.54E+05 28.57 2.14 13.36
O-Phosphoserine C3H8NO6P 3.32E+04 3.80E+03 3.55E+04 0.11 1.07 0.11
Indolelactate C11H11NO3 1.96E+04 1.11E+06 1.54E+05 56.53 7.86 7.19
Adenosine C10H13N5O4 1.04E+07 5.53E+04 1.04E+07 0.01 1.00 0.01
Inosine C10H12N4O5 3.29E+05 9.54E+04 3.86E+05 0.29 1.17 0.25
Guanosine C10H13N5O5 4.03E+05 1.54E+04 4.98E+05 0.04 1.24 0.03
MTA C11H15N5O3S 1.54E+05 6.81E+02 1.36E+05 0.00 0.89 0.00
GDP C10H15N5O11P2 0.00E+00 7.30E+04 1.48E+04 INF INF 4.95
The table shows mean peak intensities for samples from complete or uninfected MDM media (MDMc), spent media (culture supernatents) from T. vaginalis
cultures (TvagSPT) and spent media from T. foetus cultures (TfoeSPT). Values represent mean from at least 4 independent cultures. Ratios of spent media
and complete media (TvagSPT/MDMc) and (TfoeSPT/MDMc) indicate whether a metabolite is taken up or released from cells. Differences between
species are shown by the ratio of spent media (TvagSPT/TfoeSPT). P 0.005 (Paired T-Test, assuming equal variance. Except for putrescine and
spermidine, P  0.05. Full details including individual standard deviation and P values are shown in S3 Table where metabolites are also categorized
according to metabolic pathways.
HICA, 2-hydroxyisocaproate, MTA, 5-methylthioadenosine; SMC, S-methylcysteine.
https://doi.org/10.1371/journal.pone.0189072.t002
Table 3. Hydroxy acid levels in cell extracts of T. vaginalis and T. foetus.
Metabolite Formula T. vaginalis (nmol/108 cells) T. foetus (nmol/108 cells) Tvag / Tfoe
Tryptophan C11H12N2O2 28.4 18.0 1.57
Indolepyruvate C11H9NO3 0.0 0.1 0.69
Indolelactate C11H11NO3 1.3 0.5 2.77
Indoleacetate C10H9NO2 1.8 0.8 2.28
Leucine C6H13NO2 263.1 161.4 1.63
2-isocaproate C6H10O3 0.9 0.4 2.16
HICA C6H12O3 28.4 4.2 6.84
Phenylalanine C9H11NO2 124.9 86.4 1.44
Phenylpuruvate C9H8O3 0.1 0.1 1.85
Phenyllactate C9H10O3 14.0 1.3 11.03
Concentrations of metabolites in cell extracts (nmol/108 cells) were determined from peak intensity values using standard curves from at least 4 different
concentrations of the authentic standard. Tvag/Tfoe indicates the ratio of the metabolite concentration. Values in bold font represent a difference between
species of more than 3-fold, P < 0.001. HICA, 2-hydroxyisocaproate.
https://doi.org/10.1371/journal.pone.0189072.t003
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
PLOS ONE | https://doi.org/10.1371/journal.pone.0189072 December 21, 2017 9 / 34
tryptophan. 2-hydroxybutanoate derived from threonine, methionine or homocysteine was
also detected in T. vaginalis cell extracts (Table 1) and spent media (Table 2). Relatively high
peak intensities were obtained for 2-hydroxybutanoate but this metabolite was not quantified
with a calibration curve.
Arginine metabolism
The arginine dihydrolase pathway converts arginine to ornithine via citrulline and is present
in both species [31]. In addition to providing ornithine for putrescine biosynthesis, the path-
way may contribute to energy metabolism [31], producing ATP by substrate level phosphory-
lation. T. foetus had 5-fold higher levels of citrulline than T. vaginalis and ornithine levels were
increased 3-fold (Table 1). Cell extracts of the two species showed similar levels of putrescine
but T. foetus exported almost 3-fold more putrescine than T. vaginalis, as indicated by compar-
ison of spent media samples (Table 2). Other derivatives of arginine, including the organic
acid 4-guanidinobutanoate and creatinine were found at increased levels (> 5-fold) in T. vagi-
nalis (Table 1). Proline, which can be produced from arginine via ornithine, was present at
similar levels in both species although increased amounts (> 4-fold) of the proline metabolite
oxoproline were found in T. vaginalis (Table 1).
Glycolysis and central carbon metabolism
The main end products of energy metabolism in T. vaginalis are glycerol, lactate, ethanol, ace-
tate, CO2 and H2 (Fig 1A) [17]. T. foetus differs in not producing lactate but excretes high levels
of succinate. Of these metabolites, only succinate was detected by LCMS under the conditions
used in this study and as expected, levels were found to be 20-fold higher in T. foetus (Table 1)
as well as being excreted (Table 2). Central carbon metabolism in T vaginalis and T. foetus
depends primarily on glycolysis because the TCA cycle is not present [17]. Fermentation of
pyruvate is extended in the hydrogenosome with ATP production by substrate level phosphor-
ylation (Fig 1B). Levels of glycolytic intermediates showed only minor differences (<2-fold)
between the species (S2 Table) so we used stable isotope labelling to investigate whether
the two species differ in how they utilise glucose for biosynthesis and energy production. T.
vaginalis and T. foetus were grown in medium containing 100% D-[U-13C6] glucose and
Table 4. Hydroxy acid levels in spent media samples of T. vaginalis and T. foetus cultures.
Metabolite Formula MDMc (μM) TvagSPT (μM) TfoeSPT (μM) TvagSPT/ MDMc TfoeSPT/ MDMc TvagSPT/ TfoeSPT
Tryptophan C11H12N2O2 64.83 63.04 62.44 0.97 0.96 1.01
Indolepyruvate C11H9NO3 0.10 0.10 0.10 1.09 1.06 1.04
Indolelactate C11H11NO3 0.11 0.73 0.16 6.71 1.50 4.46
Indoleacetate C10H9NO2 0.88 1.12 0.89 1.28 1.02 1.26
Leucine C6H13NO2 453.68 523.67 489.31 1.15 1.08 1.07
2-isocaproate C6H10O3 1.70 1.90 1.92 1.12 1.13 1.04
HICA C6H12O3 0.39 21.42 0.52 55.01 1.34 96.42
Phenylalanine C9H11NO2 381.04 354.08 395.27 0.93 1.04 0.90
Phenylpuruvate C9H8O3 0.82 0.81 0.99 0.98 1.21 0.81
Phenyllactate C9H10O3 0.11 6.47 0.33 59.92 3.10 19.34
Concentrations of metabolites in media samples (μM) were determined from peak intensity values using standard curves from at least 4 different
concentrations of the authentic standard. Ratios of spent media and complete media (TvagSPT/MDMc) and (TfoeSPT/MDMc) indicate whether a
metabolite is taken up or released from cells. Differences between species are shown by the ratio of spent media (TvagSPT/TfoeSPT). Ratios in bold font
represent a difference between the species of more than 3-fold, P < 0.001. HICA, 2-hydroxyisocaproate.
https://doi.org/10.1371/journal.pone.0189072.t004
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Fig 1. 13C labelling of intermediates in central carbon metabolism in T. vaginalis and T. foetus. T.
vaginalis and T. foetus were grown at 37˚C in MDM containing 100% D-[U-13C6] glucose as the only
carbohydrate carbon source. Cell extracts were prepared after 2 h, 6 h and 20 h in culture and analysed by
LC-MS. (A) Map of glycolysis and central carbon metabolism in T. vaginalis and T. foetus. Reactions found
only in T. foetus are shown by dashed lines. T. vaginalis uses pyrophosphate (ppi) dependent enzymes for the
steps indicated [32]. Metabolites detected in the 13C labelling experiment are boxed. (B) Map of pyruvate
metabolism in the hydrogenosome in T. vaginalis. Dashed lines indicate the NADH dehydrogenase complex I.
Metabolites detected in the 13C labelling experiment are boxed. (C) 13C labelling of metabolites in T. vaginalis
and T. foetus. Graphs show the percentage of isotopologues with different numbers of 13C carbon atoms.
https://doi.org/10.1371/journal.pone.0189072.g001
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extracts were prepared after 2 h, 6 h and 20 h growth at 37˚C. The change in the percentage of
different 13C isotopologues was determined over the time course (Fig 1C) The total levels of
each metabolite were calculated as the sum of the peak intensities of all isotopologues and the
log2 fold change in metabolite level (T. vaginalis/T. foetus) was plotted for each time-point
(Fig 2). A heat map of percentage incorporation after 20 h is also shown in the supplementary
data (S1 Fig).
Even after 20 h growth, equivalent to four generations, 6-carbon labelled (6C) isotopologues
of G-6P still represented only 60% of the total in T. vaginalis and 80% in T. foetus (Fig 1C and
S1 Fig). Significant levels of 5C, 4C and 3C isotopologues were also detected along with unla-
belled G-6P. Similarly, 3C isotopologues of pyruvate formed 50–60% of the total detected after
20 h.
Fig 2. Comparison of total levels of intermediates in central carbon metabolism from 13C labelled extracts. Total metabolite
levels represent the sum of the peak intensities of all isotopologues. Of metabolites detected in 13C-labelled extracts. Graphs show
the log2 fold change in total peak intensities after 2 h, 6 h and 20 h growth. Results represent the mean of 3 independent
cultures ± SD. Dashed line indicates the threshold for a definite difference between the species (3-fold or log2 1.6-fold change in
metabolite level). Positive values represent a relative increase in T. vaginalis, negative values a relative increase. Glucose-6P,
glucose-6-phosphate; Triose phosphate, dihydroxyacetone phosphate and glyceraldehyde-3-phosphate; 3-PG, 3-phoglycerate; PEP,
phosphoenol pyruvate. * P 0.001 (Paired T-Test, assuming equal variance).
https://doi.org/10.1371/journal.pone.0189072.g002
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13C labelling of glycolytic intermediates pointed to differences in glycolytic flux between the
species. Although the level of incorporation into G6-P was similar, the labelling of downstream
intermediates triose phosphate (LC-MS failed to resolve 3-phosphoglycerate and dihydroxy
acetone phosphate), phosphoenolpyruvate (PEP) and pyruvate were a little higher in T. foetus
than in T. vaginalis (Fig 1C and S1 Fig). Marked differences were seen in the labelling of
metabolites of pathways branching off glycolysis. The total level of sn-glycerol-3-phosphate
(sn-G-3P) in T. vaginalis at 20 h was more than 5-fold higher than in T. foetus (Table 1 and Fig
2). The rate of labelling of sn-3-GP was also markedly higher in T. vaginalis (Fig 1C and S1
Fig) confirming that it is synthesised via the triose phosphate dihydroxyacetone phosphate
(DHAP).
T. vaginalis produces 4-fold higher levels of malate than T. foetus (Table 1). Both organisms
showed 3 carbon and 4 carbon labelling of malate, with somewhat higher levels in T. vaginalis
(Fig 1C). 3C and 4C labelled isotopologues of succinate in T. foetus represented 46% and 24%
of the total at 20 h, respectively (Fig 1C and S1 Fig), whereas the relatively low levels detected
in T. vaginalis were unlabelled. In T. vaginalis, malate is produced from PEP as an intermediate
in energy metabolism but in T. foetus, this pathway is extended to convert malate to succinate
as an end product (Fig 1A) [17]. The 3C and 4C isotopologues of aspartate would have been
produced by transamination of labelled oxaloacetate. T. vaginalis showed higher rates of 13C
labelling (Fig 1C and S1 Fig), although at 20 h the total levels of aspartate in the two species
were similar (Fig 2).
Alanine is produced by transamination of pyruvate catalysed by alanine aminotransferase.
3C labelled alanine increases from 16% of the total at 2 h to 33% at 20 h in T. vaginalis, 5 fold
higher than that seen in T. foetus (Fig 1C). Acetyl-CoA is produced in the hydrogenosome
from pyruvate by pyruvate:ferredoxin oxidoreductase (Fig 1B). Total levels of acetyl-CoA were
significantly higher in T. vaginalis (Fig 2), with 2C isotopologues making up roughly 50% of
the total throughout the time course (Fig 1C). A more complex pattern of labelling was seen in
T. foetus with 2C isotopologues representing 60% of the total after 2 h growth but with 2C and
7C isotopologues representing 27% and 26% of the total, respectively, after 20 h (Fig 1C). A 2C
labelled acetyl group is incorporated into acetyl-CoA from 3C labelled pyruvate, but label can
also be incorporated during coenzyme A biosynthesis.
Differences in methionine metabolism
The T. vaginalis genome encodes all the enzymes required to produce homocysteine from
methionine but the transsulfuration pathway for conversion of homocysteine to cysteine via
cystathionine was not found (Fig 3) [12, 19]. Using calibration curves, extracts of the two spe-
cies were shown to have similar levels of methionine and SAM but T. foetus contained approxi-
mately 5-fold higher levels of SAH (Fig 3). Thiols are readily oxidised in situ during LC-MS
and this is most likely the reason why homocysteine was not detected in cell extracts. However,
a metabolite identified as a mixed disulfide of homocysteine and cysteine by MS2 was found in
T. foetus extracts but not in T. vaginalis, indicating that higher levels of homocysteine are pro-
duced in T. foetus. Similarly, T. foetus apparently has a higher intracellular concentration of
cysteine, indicated by the detected levels of its oxidised form, the disulfide cystine. In another
clear difference between the species, cystathionine was identified in T. foetus (34 nmol/108
cells) but it was almost undetectable in T. vaginalis (2 nmol/108 cells) (Fig 3). Both species pro-
duce relatively high levels of methylthioadenosine (MTA) with 120 nmol/108 cells in T. vagina-
lis and 270 nmol/108 cells in T. foetus. An unusual metabolite, SMC was also detected in T.
vaginalis as detailed in subsequent sections.
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Fig 3. Metabolomic analysis of methionine and cysteine metabolism in T. vaginalis and T. foetus. T.
vaginalis and T. foetus were grown for 20 h at 37˚C in MDM which contains no added cysteine. Graphs show
concentrations of metabolites (nmol/108 cells) calculated from peak intensity values using standard curves.
There were no standards available for the mixed disulfide of cysteine and homocysteine (Cys:Hcy disulfide)
and its concentration is represented by peak intensity/108 cells. Broken lines indicate the oxidation of sulfur
amino acids to form disulfides. Enzymes found in the T. vaginalis genome are: 1, S-adenosylmethionine
synthase; 2, S-adenosylmethionine dependent methyltransferase; 3, S-adenosylhomocysteine hydrolase; 4,
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
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Labelling of intermediates in nucleotide and methionine metabolism
T. vaginalis and T. foetus were grown in 13C-glucose which was expected to label SAM via ATP
(Fig 4A). The oxidative branch of the pentose phosphate pathway is active in T. vaginalis and
T. foetus, with both organisms showing similar levels of 13C incorporation into ribose-5-phos-
phate after 20 h (Fig 4C, S2 Fig). Ribose-5-phosphate is used to synthesise nucleotides as
shown by the presence of 5C isotopologues of UTP, GTP and ATP (Fig 4C, S2 Fig). No labelled
pyrimidine or purine bases were detected indicating that nucleotides are synthesised by scav-
enging or recycling pathways with no evidence of de-novo synthesis, as reported for T. vaginalis
previously [33, 34]. Higher percentages of C5 labelled nucleotides are seen in T. foetus com-
pared to T. vaginalis, most markedly in GTP, GDP and UTP (S2 Fig). This could be explained
by differences in the capacity of the two organisms for uptake unlabelled nucleosides as nucle-
otide precursors (Table 2).
Methionine was not labelled by 13C in T. vaginalis or T. foetus (Fig 4C) but 5C isotopologues
of SAM and SAH were identified in both species (Fig 4C, S3 Fig). SAM is synthesised from
methionine and ATP and then converted to SAH by transmethylation. The higher levels of
incorporation in T. foetus are consistent with the relatively high labelling of ATP in this species
(Fig 4C, S3 Fig), and do not necessarily indicate an increased rate of synthesis. C5 isotopolo-
gues of SAM and SAH were more abundant in T. foetus, again reflecting the relative incorpo-
ration of the label in the intracellular pool of ATP (Fig 4C, S3 Fig). High levels of cystathionine
were detected in T. foetus and C3-labelled isotopologues increased with time, representing
60% of the total after 20 h growth (Figs 4C and 5). In contrast, the low level of cystathionine
detected in T. vaginalis were not labelled (Figs 4C and 5).
Effect of propargylglycine on methionine metabolism in T. vaginalis
T. vaginalis produces MGL, a broad specificity enzyme that hydrolyses methionine, homocys-
teine and cysteine although biochemical analysis failed to detect this activity in cell extracts of
T. foetus [18, 29, 35]. To determine whether the differences in MGL activity could account for
the observed differences in methionine metabolism, T. vaginalis cultures were grown in the
presence of 5 μM propargylglycine (PAG), a strong inhibitor of the T. vaginalis MGL. This
resulted in a marked increase in the levels of methionine, SAM and SAH (Fig 6). The Cys:Hcy
mixed disulfide was also detected in PAG-treated cell extracts, showing that more homocyste-
ine was produced as reported previously [20]. Growth of T. vaginalis with 10 mM cysteine also
affected methionine metabolism with increased levels of SAM, cystine and the Cys:Hcy mixed
disulfide. (Fig 6). Interestingly, T. vaginalis has the capacity to synthesise cystathionine because
when grown in medium containing added 10 mM cysteine or when cells are treated with 5 μM
PAG, levels of cystathionine in cell extracts increased to 7.2 and 6.5 nmol/108 cells, respectively
(Fig 6).
Identification of S-methyl-L-cysteine as a metabolite in T. vaginalis but
not in T. foetus
One cellular metabolite found in the study was initially identified as homocysteine on the basis
of accurate mass (m/z 135.0354). However, its retention time of 11.11 min differed from that
methionine γ-lyase (MGL); 5, cysteine synthase (CS); 6, 1-aminocyclopropane-1-carboxylic acid (ACC)
synthase. CS from T. vaginalis is a multi-functional enzyme with broad specificity, as demonstrated in later
sections. * More than 3-fold difference between species. P 0.001 (Paired T-Test, assuming equal
variance).
https://doi.org/10.1371/journal.pone.0189072.g003
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Fig 4. 13C labelling of intermediates in nucleotide and methionine metabolism in T. vaginalis and T.
foetus. T. vaginalis and T. foetus were grown at 37˚C in MDM containing 100% D-[U-13C6] glucose as the
only carbohydrate carbon source. Cell extracts were prepared after 2, 6 and 20 h in culture and analysed by
LC-MS. (A) Map showing pathway from glucose to nucleotide and methionine metabolism in T. vaginalis and
T. foetus. Reactions found only in T. foetus are shown by dashed lines. Formation of cystathionine from
cysteine and homocysteine has not been confirmed. Metabolites detected in the 13C labelling experiment are
boxed. (B) Map showing metabolites labelled with 13C via the glycolytic intermediate 3-phosphoglycerate.
Metabolites detected in the 13C labelling experiment are boxed. (C) 13C labelling of metabolites in T. vaginalis
and T. foetus. Graphs show the percentage of isotopologues with different numbers of 13C carbon atoms,
error bars show standard deviation.
https://doi.org/10.1371/journal.pone.0189072.g004
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of the authentic homocysteine standard (15.98 min). Thus, fragmentation analysis was carried
out and this revealed that the metabolite was S-methyl-L-cysteine (SMC), a thioether analogue
of methionine in which a methyl group is linked to the sulfur atom of cysteine (S4 Fig). The
most abundant fragment (Fragment 1, 119.0161, C4H7O2S) corresponded to loss of the
amino group and fragments with much lower peak intensities to loss of the carboxylate group
Fig 5. Comparison of total levels of intermediates in nucleotide and methionine metabolism from extracts of 13C labelled
cells. Total metabolite levels represent the sum of the peak intensities of all isotopologues of metabolites detected in extracts of 13C
labelled cells. Graphs show the log2 fold change in total peak intensities after 2, 6 and 20 h growth. Results represent the mean of 3
independent cultures ± SD. Dashed line indicates the threshold for a definite difference between the species (3-fold or log2 1.6-fold
change in metabolite level). Positive values represent a relative increase in T. vaginalis, negative values a relative decrease.
Ribose-5P, Ribose-5-phosphate; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; MTA, 5-methylthioadenosine;
OPS, O-phosphoserine; SMC, S-methylcysteine. * P 0.001 (Paired T-Test, assuming equal variance).
https://doi.org/10.1371/journal.pone.0189072.g005
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(Fragment 2, 90.0372, C3H8NS) and to loss of the methyl-sulphur and amino groups (Frag-
ment3, 73.0285, C3H5O2). Generation of the latter fragment arises from cleavage of a carbon-
sulphur bond in SMC but requires cleavage of a high energy carbon-carbon bond in the SMC
isomer homocysteine; this, makes SMC the most likely identification of the parent compound.
Moreover, the fragmentation pattern was identical to those seen in MS2 spectra for SMC pub-
lished on HMBD (http://www.hmdb.ca) and quite distinct from those obtained for homocys-
teine. Subsequently, we confirmed that an authentic SMC standard had the same retention
time as the metabolite identified. SMC is a characteristic of T. vaginalis with only very low lev-
els detected in T. foetus ( 200-fold lower peak intensity) (Table 1, Figs 3 and 5).
Fig 6. Effect of growth conditions on methionine metabolism in T. vaginalis. T. vaginalis and T. foetus were grown for 20
h at 37˚C in MDM which contains no added cysteine (MDM), MDM with 10 mM cysteine (CYS) or MDM with 5 μM
propargylglycine (PAG). Cell extracts were analysed by LC-MS and the ratios of metabolite peak intensities for different
growth conditions were determined. The graph show the log2 of the ratios CYS/MDM and PAG/MDM ± SD. The dotted lines
indicate a difference in peak intensity 3 (or log2 1.6).* P 0.001 (Paired T-Test, assuming equal variance).
https://doi.org/10.1371/journal.pone.0189072.g006
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Using a standard curve, the concentration of SMC found in T. vaginalis extracts was 11.1
nmol/106 cells but the level in T. foetus was only 0.09 nmol/106 cells. SMC was also detected in
spent media from T. vaginalis cultures, reaching 2.4 μM after 20 h growth, 20-fold higher than
uninfected medium. These results indicate that SMC is produced in T. vaginalis and released
into the medium.
Levels of SMC in T. vaginalis are correlated with the levels of CS
T. vaginalis produces several isoforms of a cysteine synthase (CS), an enzyme linked to SMC
production in Entamoeba histolytica [36]. To investigate whether CS could also be involved in
SMC synthesis in T. vaginalis cells were grown under conditions known to affect the levels of
CS expression and enzyme activity [19]. Intracellular SMC levels were found to be 50-fold
lower in cells grown in medium containing 10 mM cysteine (Fig 6). Under the same condi-
tions, CS activity was previously shown to be reduced 10-fold [19], thus raising the possibility
that the T. vaginalis CS is involved in SMC synthesis. Treatment with 5 μM PAG resulted in a
4-fold reduction in the amount of SMC (Fig 6) even though cysteine synthase activity is
increased [19]. However, under these conditions production of CH3SH, required for synthesis
of SMC, is markedly reduced by inhibition of MGL.
SMC is produced by CS in vitro
To determine whether the T. vaginalis CS could synthesise SMC, an in vitro assay was devel-
oped based on the finding that the SMC is a substrate for T. vaginalis MGL [35]. SMC was
quantified in a coupled assay with recombinant T. vaginalis MGL type 1 (TvMGL1) [29] and
lactate dehydrogenase (LDH). In this, SMC is catabolised by TvMGL1 to pyruvate, CH3SHand
ammonia in the first reaction and pyruvate is reduced to lactate by LDH with oxidation of
NADH in the second (Fig 7A). The production of SMC from OPS and CH3S.Na by CS was
monitored by measuring the rate of NADH oxidation. After a lag period of about 10 min, a lin-
ear rate was maintained for more than 15 min (Fig 7B). SMC synthase activity was propor-
tional to CS concentration in the range 25 to 125 nM. A substrate saturation curve for
reactions with a fixed concentration (10 mM) of O-phosphoserine and 0.25–12 mM CH3S.Na
exhibited Michaelis Menton kinetics with a Km for CH3S.Na of 4.3 mM (Fig 7C).
Cysteine is also hydrolysed by MGL so the assay can be used to measure cysteine produc-
tion by substituting Na2S for CH3SNa. This allowed a comparison of the kinetics of cysteine
and SMC production by CS using the same assay (Table 5). The Km for Na2S was found to be
10-fold lower than that for CH3SNa. The catalytic efficiency of the CS reaction with Na2S was
20-fold higher than for synthesis of SMC with CH3S.Na (Table 5).
13C labelling of cysteine, SMC and serine via glyceraldehyde-
3-phosphate
Based on measurement of cystine, T. foetus contains higher intracellular concentration of cys-
teine than T. vaginalis (Fig 5) and higher rates of 13C incorporation from glucose (Fig 4C). In
contrast, 13C incorporation from glucose into cystine in T. vaginalis was<10% even after 20 h
growth. Similarly, 80% of the SMC detected in T. vaginalis cells after 20 h growth was unla-
belled, whereas the very low levels of SMC detected in T. foetus showed high percentage incor-
poration (Fig 4C). Clear evidence of SMC synthesis in T. vaginalis is shown, however, by the
increase in peak intensity of the 3 carbon-labelled isotopologue with time (Fig 8A) and the
increasing amounts of SMC released into the growth medium (Fig 8B). Intracellular levels of
the 13C isotopologue of OPS, the precursor of cystine and SMC, increased with time (Fig 8C).
However labelled OPS represented markedly lower percentage of the total in T. vaginalis
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Fig 7. SMC biosynthesis by T. vaginalis CS. Production of SMC from OPS and CH3S.Na by recombinant T. vaginalis CS was
determined at 37˚C. (A) A coupled assay for SMC synthase. The assay couples SMC production by CS to NADH oxidation using MGL and
LDH. The rate of NADH oxidation and hence the rate of SMC production can be quantified by measuring the absorbance at 340 nm. (B)
The effect of increasing amounts of CS in a coupled assay for SMC biosynthesis. The reaction contained 10 mM OPS, 3 mM CH3SNa and
0, 1 and 5 μg/ml CS. The graph shows the rate of NADH oxidation which is equivalent to the rate of SMC biosynthesis in the coupled
assay. (C) Substrate saturation curve for CH3SNa. Reactions contained 10 mM OPS, 85 nM CS and 0.25–12 mM sodium CH3SNa. A plot
of enzyme activity against CH3SNa concentration shows Michaelis-Menten kinetics.
https://doi.org/10.1371/journal.pone.0189072.g007
Table 5. Kinetic analysis of SMC synthase and CS synthase activities of T. vaginalis CS.
Enzyme activity Substrate Vmax (nmol/min/mg) Km (mM) kcat(S-1) kcat/Km (M-1s-1)
SMC synthase CH3SNa (with 10 mM OPS) 7.3 ± 2.4 4.3 ± 1.6 4.1 1.0 x 103
OPS (with 3 mM CH3SNa) 4.4 ± 1.4 4.6 ± 1.9 2.5 5.5 x 102
Cysteine synthase Na2S (with 50 mM OPS) 130 ± 3.6 0.4 ± 0.8 0.2 2.3 x 104
OPS (with 3 mM Na2S) 20.4 ± 4.2 18.2 ± 0.8 11.5 6.4 x 102
https://doi.org/10.1371/journal.pone.0189072.t005
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(Fig 8C). Levels of OPS in the growth medium decreased 10-fold during the course of the T.
vaginalis culture but there was no change in the complete medium control or in the T. foetus
spent medium (Fig 8D). Overall, these results indicate that T. vaginalis imports OPS from the
medium, reducing the amount that is synthesised from glucose. 13C labelling also revealed that
both T. vaginalis and T. foetus can synthesise serine from phosphoserine, even though a search
of the T. vaginalis genome database failed to detect a gene for the phosphatase required ([19].
The percentage of 3 carbon labelled serine in T. foetus was 2-fold higher than in T. vaginalis,
again consistent with the lower incorporation of label into OPS in the latter.
Fig 8. Synthesis of OPS and SMC in T. vaginalis and T. foetus. Cell extracts prepared after 2, 6 and 20 h growth at 37˚C in media
containing 100% D-[U-13C6] glucose were analysed by LC-MS. Graphs show the mean peak intensities of 3-carbon labelled isotopologues
from 3 biological replicates (± SD). (A) 13C labelled SMC in cell extracts; (B) total SMC levels in media samples; (C) 13C labelled OPS in cell
extracts; (D), total OPS levels in media samples. Complete, uninfected or complete media control; TvagSPT, spent media sample from T.
vaginalis cultures; TfoeSPT, spent media from T. foetus cultures.
https://doi.org/10.1371/journal.pone.0189072.g008
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Identification of other thioethers including allylcysteine
The T. foetus extracts contained allycysteine, a thioether with a similar structure to SMC in
which the cysteine sulphur is linked to a propenyl group rather than a methyl group. Allylcys-
teine was identified by comparison with an authentic standard in T. foetus extracts (S2 Table)
Allylcysteine was barely detectable in T. vaginalis extracts, its sulfoxide derivative, alliin was
found at 10-fold higher peak intensity than obtained for T. foetus. The mechanism of allylcys-
teine production is not known, although in contrast to results obtained with SMC, we detected
allylcysteine in medium containing 10 mM cysteine after overnight incubation at 37˚C in the
absence of cells. This shows that allylcysteine can be formed spontaneously from media com-
ponents under certain conditions. We conclude that allylcysteine and alliin are unlikely to be
true metabolites of the trichomonads and that SMC is the only thioether detected that is
synthesised by T. vaginalis.
Genome analysis of T. foetus strain K
A draft sequence of the genome of T. foetus strain K was released while this manuscript was in
preparation [13]. We therefore searched the genome for the genes of key enzymes involved in
amino acid metabolism (S6 Table). T. vaginalis encodes several isoforms of a highly specific
malate dehydrogenase (MDH) and a closely related lactate dehydrogenase (LDH) but T. foetus
genome contained only an MDH, consistent with biochemical evidence that the parasite did
not produce lactate [17]. An alignment of the T. foetus MDH proteins with the T. vaginalis
MDH and LDH is shown in S5 Fig. T. foetus K encodes 3 isoforms of cysteine synthase, and
the enzymes required for phosphoserine production from 3-phosphoglycerate but a gene for
serine-O-acetyltransferase was not found (S6 Table). T. foetus might therefore synthesise cyste-
ine from H2S and phosphoserine as reported for T. vaginalis [19]. The enzymes of the transsul-
furation pathway, including CBS, were absent but unexpectedly, T. foetus appears to contain 4
isoforms of MGL (S6 Table). These T. foetus proteins have 69–72% amino acid identity with
the T. vaginalis MGL isoforms and key active site residues required for PLP binding and a cys-
teine implicated in specificity for methionine are conserved (S6 Fig). This new finding is not
consistent with previous biochemical analyses of T. foetus cell extracts [18].
Discussion
Genomic analysis, transcriptomics and proteomics of T. vaginalis have identified potential sur-
face proteins, secretory proteins and peptidases as virulence factors that may be involved in
cell adhesion, cytotoxicity and pathogenesis [12, 37–46]. Recent studies have investigated the
effect of different growth conditions on gene expression in T. vaginalis [46–48]. This is the first
report of the use of metabolomics on trichomonad species, providing reference metabolic pro-
files of T. vaginalis and T. foetus and demonstrating how this approach can be used to identify
new or unusual metabolites, compare species and identify changes in the levels of soluble
metabolites occurring under different growth conditions. This study also revealed the effect of
propargylglycine, an inhibitor of PLP-dependent enzymes, on the T. vaginalis metabolome.
Central carbon metabolism in T. vaginalis and T. foetus
Glycolytic intermediates were labelled by growing cells for various times in media containing
D-[U-13C6] glucose as the only carbohydrate carbon source. Failure to obtain 100% 13C label-
ling of G-6P suggests that trichomonads can use an alternative source of carbon skeletons for
gluconeogenesis such as amino acids. This would also explain the range of different isotopolo-
gues of G-6P detected in T. vaginalis, an organism that readily takes up amino acids from the
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growth media [49]. These studies revealed differences in metabolic fluxes between the species.
The level and rates of incorporation into G-6P and triose-P were similar, and labelling of
downstream intermediates 3-PG, PEP and pyruvate were only slightly higher in T. foetus than
in T. vaginalis. However, marked differences were seen in the labelling of metabolites of path-
ways branching off glycolysis. The rate of labelling of sn-G-3P via the triose-P DHAP was
higher in T. vaginalis. Sn-G-3P is converted to glycerol, an end product of glucose metabolism
in both species and it is a precursor of phosphatidic acid in glycerophospholipid biosynthesis.
There were also differences in the levels of metabolites produced from PEP including malate,
succinate and aspartate.
T. vaginalis encodes a PEP carboxykinase that produces OAA from PEP and CO2. OAA
was not detected by LC-MS, but the products of its metabolism were found in extracts of both
species. C3 and C4 isotopologues of malate, succinate and aspartate were identified when cells
were grown in D-[U-13C6] glucose, with the C4 isotopologues accumulating at later times.
OAA is reduced to malate by malate dehydrogenase (MDH) or transaminated to aspartate by
aspartate aminotransferase (AAT). Total levels of malate were 5-fold higher in T. vaginalis and
percentage 13C labelling was also higher, with C4 species more abundant than in T. foetus. This
is no doubt due to the conversion of malate to succinate (via fumarate) which occurs in T. foe-
tus but not in T. vaginalis [17]. T. foetus extracts contained 20-fold higher levels of succinate
and the low level of succinate detected in T. vaginalis was not significantly labelled and most
likely imported from the media. These results agree with previously published data [17] and
validate our methods.
The high levels of incorporation of 13C into aspartate, particularly in T. vaginalis extracts
were not expected. In T. vaginalis multiple isoforms of AAT convert OAA and glutamate to
aspartate and α-ketoglutarate [12]. However, it is not clear why T. vaginalis produces such
high levels of aspartate, with 70% 13C labelled at 20 h, even when aspartate is available in the
medium. T. vaginalis produces cytoplasmic and hydrogenosomal isoforms of MDH and AAT
that could function in an aspartate:malate shuttle [40]. Antiporters required for transport of
reducing equivalents across the hydrogenosomal membranes were not identified although the
proteome contains several mitochondrial carrier family (MCF) proteins [40] An active aspar-
tate:malate shuttle would explain the high rate of aspartate synthesis observed in this study.
Hydrogenosomes do not have an electron transport system but NADH is required by the
hydrogenosomal pyruvate:ferrodoxin oxidoreductase and reduced ferrodoxin is an electron
donor for hydrogenase and the oxygen scavenging flavodiiron protein [50].
Cysteine and SMC are produced in T. vaginalis using a bi-functional CS
Cysteine was detected predominantly in its oxidised form by LC-MS. Levels of cystine were
20-fold higher in T. foetus cell extracts than in T. vaginalis indicating that T. foetus maintains
higher intracellular cysteine levels. Both organisms lack glutathione and glutathione-depen-
dent enzymes and cysteine is thought to be a major intracellular reductant. 13C-labelling dem-
onstrated that cysteine is synthesised from OPS in both trichomonad species, although the
percentage incorporation was low in T. vaginalis, most likely due to its ability to take up unla-
belled OPS from the medium. Surprisingly, OPS can be converted to serine in T. vaginalis and
T. foetus, even though no homologues of the phosphatase required could be detected in the T.
vaginalis genome [19].
We show that T. vaginalis produces SMC, an unusual metabolite that has limited distribu-
tion in nature. It is found in the seeds of leguminous plants and was recently detected in the
protozoan parasite Entamoeba histolytica [36] which resembles T. vaginalis in lacking mito-
chondria and having a fermentative metabolism. E. histolytica uses CS to produce SMC, and
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we found that the T. vaginalis CS can also produce SMC in vitro from CH3SH and OPS. The
catalytic efficiency of the T. vaginalis CS with CH3SH was 20-fold lower than with H2S in the
production of cysteine whereas the E. histolytica CS showed no preference for either substrate.
CH3SH and H2S are produced by MGL and both metabolites have been detected in T. vaginalis
[51], although their intracellular concentrations are not known.
E. histolytica is dependent on an exogenous source of cysteine [36] and growth in medium
containing 13C3, 15N-serine labelled SMC but not cysteine, indicating that the E. histolytica CS
functioned solely as an SMC synthase [36]. In contrast, T. vaginalis grows well in medium
without cysteine and levels of CS are regulated by conditions that affect cysteine availability
[19]. Metabolomic profiling revealed that SMC levels are affected by the same conditions and
both SMC and cysteine incorporated similar levels of 13C. These results suggest that the T.
vaginalis CS is a bi-functional enzyme producing both cysteine and SMC. Cysteine is the main
intracellular antioxidant in T. foetus whereas T. vaginalis contains both cysteine and SMC. In
this study we measured an SMC concentration of 200 μM using LC-MS which compares with
a concentration of 600 μM for cysteine [20]. The function of SMC is not known, but recent evi-
dence indicates a role in other species in protection against oxidative stress [52–54] and
inflammation [55].
HPLC analysis revealed that the sulfur atom of SMC is oxidised by H2O2 and the SMC-sulf-
oxide can be reduced by the enzyme methionine sulfoxide reductase (MSRA) in vitro [52]. In
an animal model for Parkinson’s disease based on a recombinant Drosophila line expressing
human α-synuclein, disease symptoms were reversed either by overexpressing human MSRA
in a doubly transgenic line or by feeding with SMC, which is not produced naturally in the
fruitfly [52]. It was proposed that the beneficial effects of SMC resulted from its reversible oxi-
dation in an antioxidant system for scavenging free radicals and peroxides. In this system, con-
sisting of SMC, MSRA, thioredoxin and thioredoxin reductase, SMC is oxidised by peroxides
to form the SMC sulfoxide and this is reduced by MSRA in a thioredoxin dependent reaction.
All the components of this system are found in T. vaginalis [12, 56–58] and it is possible that
SMC acts as an antioxidant in T. vaginalis also.
Role of MGL in methionine metabolism in T. vaginalis
In most organisms, including protozoan parasites, methionine is activated to SAM by methio-
nine adenosyltransferase [59]. SAM plays a central role in cell metabolism as a methyl donor
for the methylation of nucleic acids, lipids and proteins and as a source of aminopropyl groups
for spermidine synthesis. SAH produced as a bi-product of SAM-dependent methyltransferase
reactions is converted to homocysteine which is rapidly removed either by re-methylation to
methionine or by conversion to cysteine by the transulfuration pathway. In the first, rate limit-
ing step of transsulfuration, homocysteine is condensed with serine to form cystathionine, cat-
alysed by cystathionine β-synthase (CBS). Cysteine is then synthesised by hydrolysis of
cystathionine catalysed by cystathionine γ-lyase (CGL).
In mammals, CBS maintains low homocysteine levels, which is thought to be necessary for
adequate rates of SAM-dependent methylation [60, 61]. Serum homocysteine levels are
increased 10–30 fold in individuals with genetic defects in CBS or in CBS knockout mice
resulting in accumulation of SAH. This is because the SAH hydrolase reaction is reversible and
the kinetics in vitro favour the synthesis of SAH over its hydrolysis. SAH is a strong product
inhibitor of many SAM-dependent methyl transferases and it has been hypothesised that
increased homocysteine and SAH levels could induce epigenetic effects due to DNA hypo-
methylation. Tissue-specific hypomethylation has been linked to CBS knockout mutation in
mice [61, 62] although conflicting results were recently reported [63].
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The T. vaginalis genome encodes several isoforms of methionine adenosyl transferase and
SAH hydrolase (S6 Table) [12]. Only one potential SAM-dependent methyltransferase was
found in the genome although earlier, biochemical evidence demonstrated that transmethyla-
tion reactions take place in T. vaginalis and T. foetus [64]. The transulfuration pathway was not
found in T. vaginalis but this species produces a broad specificity MGL that hydrolyses homo-
cysteine, methionine and cysteine [29, 35].
In this study, the concentration of SAH in cell extracts was higher in T. foetus compared
with T. vaginalis. In addition, homocysteine was detected as a mixed disulfide with cysteine in
T. foetus extracts with a peak intensity of 1.0 x 105 but was not detected in T. vaginalis, indicat-
ing that T. foetus cells have significantly higher levels of homocysteine. Higher levels of homo-
cysteine and SAH would be expected to inhibit SAM-dependent methyltransferases and it is
therefore interesting that lower rates of methylation have been reported in T. foetus compared
with T. vaginalis [64].
When T. vaginalis was grown in media containing 5 μM propargylglycine, a potent inhibi-
tor of MGL, the concentrations of all metabolites in the trans-methylation pathway were sig-
nificantly increased, particularly SAH and homocysteine (detected as a mixed dislfide with
cysteine). Methionine and homocysteine are hydrolysed by MGL so an increase in their intra-
cellular levels was expected. SAH is a relatively poor substrate of MGL in vitro [35] so
the> 100-fold increase in SAH we observed could be linked to the elevated intracellular levels
of homocysteine and the resulting shift in the equilibrium of SAH hydrolase reaction towards
synthesis of SAH. Thus it appears that one of the functions of MGL is the rapid removal of
homocysteine, a function attributed to CBS in other organisms.
We show that T. foetus extracts contained high levels of cystathionine but only very low lev-
els were detected in T. vaginalis grown under the same conditions. This suggests that T. foetus
could have a different mechanism for the regulation of homocysteine levels. Cystathionine was
labelled in T. foetus when cells were grown with D-[U-13C6] glucose and is therefore synthe-
sised, possibly by a previously unidentified CBS activity using serine and homocysteine or by
CS using cysteine and homocysteine, as reported in vitro for the E.coli CysM [65], an ortholo-
gue of the T. vaginalis CS [19]. Interestingly, T. vaginalis has the capacity to produce cystathio-
nine when cells are grown in media containing added 10 mM cysteine or when MGL is
inhibited by PAG, resulting in elevated intracellular homocysteine levels. We have shown pre-
viously that the T. vaginalis CS can produce S-2-hydroxyethyl-L-cysteine and H2S from cyste-
ine and β-mercaptoethanol [19] but the production of cystathionine by the same mechanism
was not investigated.
Failure to detect MGL activity in T. foetus or other trichomonad species by biochemical
analysis [18] provides a simple explanation for the relatively low levels of SMC and the
increased levels of homocysteine found in T. foetus. However, we found that the recently
released draft genome sequence for T. foetus strain K [13] encoded 4 copies of a putative MGL.
How can the previous biochemical studies and our new metabolomics analysis be reconciled
with these predictions based on sequence analysis? It is possible that SMC is produced in T.
foetus but is then rapidly converted to another metabolite. For example, cysteine could be
formed by de-methylation of SMC. Alternatively, CH3SH produced from methionine could be
utilised in alternative reaction. However, a more plausible explanation is that the putative
MGL genes of T. foetus encode proteins adapted for another function. Like many PLP-depen-
dent enzymes, MGL shows a range of different activities in vitro. Hydrolysis of methionine to
produce 2-ketobutyrate, ammonia and CH3SH is the result of an α, γ elimination reaction and
MGL enzymes from different organisms can use cysteine, homocysteine or cystathionine as
alternative substrates in the same reaction with varying efficiency [66] Isoforms within a spe-
cies show differences in substrate specificity as observed in T. vaginalis (29) and E. hystolytica
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[67] and the specificity of MGL can be altered by mutation of active site residues [29]. Cysteine
and substituted serines including O-acetylserine and OPS are hydrolysed in vitro by an alterna-
tive α, β elimination reaction and β or γ replacement reactions are also possible. Functional
analysis of the MGL from A. thaliana suggested a role in an alternative pathway for cysteine
biosynthesis from methionine involving CH3SH [68]. The pathway was not determined but it
was proposed that MGL catalysed a replacement reaction involving CH3SH that resulted in
the release of H2S that could be used by CS for cysteine biosynthesis. Interestingly, kinetic
analysis of the A. thaliana MGL showed that the efficiency of the α, γ -elimination reaction for
hydrolysis of methionine was 3-orders of magnitude lower than that for MGLs from other
organisms, leading to the suggestion that a replacement reaction is indeed preferred by the A.
thaliana MGL [66]. Thus the catalysis of alternative reactions by MGL may be significant in
vivo and MGL seems likely to perform different functions in different organisms. In this study
we propose that MGL in T. vaginalis is involved in the removal of homocysteine and produc-
tion of CMC via CH3SH. This study has shown that the same does not appear to be the case
for the putative MGL identified in the T. foetus genome. Further investigation, including
detailed kinetic analysis of recombinant proteins, is needed to determine the function served
by the putative T. foetus MGL. We have shown that cystathionine is produced and exported by
T. foetus but was detected only at very low levels in T. vaginalis. Perhaps the putative MGL iso-
forms of T. foetus produce cystathionine from cysteine and homocysteine by a β-replacement
mechanism as reported for the E. coli CysM.
In mammals and many other organisms SAM decarboxylase produces decarboxylated
SAM which acts as donor of aminopropyl groups for spermidine synthesis, producing
methylthioadenosine (MTA) as a by-product. Trichomonas lacks SAM decarboxylase and does
not synthesise spermidine, nevertheless high levels of MTA were identified in the metabolomic
profiles of T. vaginalis and T. foetus. Incorporation of 13C confirmed that MTA was produced
from SAM by an unusual mechanism. The T. vaginalis genome encodes a homolog of 1-ami-
nocyclopropane-1-carboxylate (ACC) synthase, a plant enzyme that converts SAM to ACC
and MTA [69]. As a standard, ACC gave a peak with a retention time of 12.34 but ACC was
not found in cell extracts or media samples, suggesting that it is rapidly converted. In plants
ACC is the precursor of the ripening hormone ethylene but there is no evidence of ethylene
production in these trichomonads. MTA is a precursor in the methionine regeneration path-
way in many organisms. Working with T. vaginalis cell extracts, Berger and co-workers identi-
fied an aminotransferase required for the last step in the pathway [70]. The aminotransferase
converted ketomethiobutyrate to methionine in vitro and showed a strong preference for
lysine as an amino donor. However, failure to detect 13C labelled methionine in our study does
not support methionine recycling.
2-Hydroxy acids are produced in T. vaginalis using LDH
T. vaginalis converts several amino acids to 2-hydroxy acid derivatives which are exported into
the medium whereas only low levels of these metabolites were detected in T. foetus. 2-hydroxy
acids are produced by deamination of amino acids to form the corresponding 2-keto acid fol-
lowed by reduction using an NADH dependent 2-hydroxy acid dehydrogenase. T. vaginalis
encodes a branch-chain amino acid aminotransferase that transaminates leucine [71] to form
2-isocaproate. A broad specificity aspartate aminotransferase has activity with aromatic amino
acids in vitro including phenylalanine and tryptophan [72], to produce phenylpyruvate and
indole-3-pyruvate. In addition, 2-ketobutyrate can be formed from threonine by threonine
dehydratase and from methionine or homocysteine by MGL. There is good evidence that
these 2-keto-acid derivatives are converted to the corresponding hydroxy acids by a broad
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specificity LDH. Six isoforms of LDH were resolved from T. vaginalis extracts by isoelectric
focussing and two of these showed high activity for ketobutyrate and 2-isocaproate [73].
One of the LDH isoforms, purified as a recombinant protein, has malate dehydrogenase
(MDH) activity in addition to LDH activity [74]. This is unusual because 2-hydroxy acid dehy-
drogenases generally have a high specificity either for oxaloacetate or pyruvate. Based on
sequence analysis it was proposed that LDH evolved from cytoplasmic MDH by gene duplica-
tion and mutation. The T. vaginalis genomic sequence encodes 10 isoforms of LDH with
between 57% and 94% amino acid identity. These most likely have different substrate specific-
ity, accounting for the wide range of hydroxy acids detected. The absence of biochemical evi-
dence for LDH activity in T. foetus explains why only negligible amounts of hydroxy acids are
detected in cell and media extracts. A search of the draft genome sequence of T. foetus strain K
identified 4 isoforms of a putative MDH containing the conserved ‘specificity’ residue (S5 Fig)
[74] but failed to detect any homolog of the T. vaginalis LDH (S6 Table).
Lactate is a major product of energy metabolism in T. vaginalis and the main function of
LDH in T. vaginalis is likely to be redox balance. However, T. vaginalis also produces very high
levels of HICA suggesting that catabolism of leucine by this route is important to the organism.
HICA is produced by lactic acid bacteria and was recently shown to have antimicrobial [75–
77] and anti-inflammatory activity [78]. HICA can also improve muscle recovery by inducing
an increase in protein synthesis through mTOR signalling [79], which also regulates the innate
immune response to bacterial, fungal or parasitic infection. The healthy vaginal microbiome is
dominated by H2O2- and lactic acid-producing lactobacillus species forming a biofilm on the
cervico/vaginal mucosa that protects against bacterial vaginosis, although not against tricho-
moniasis. Trichomonas infection alters the microbiome, thereby increasing vaginal pH. It is
worth investigating whether HICA or other 2-hydroxy acids produced by T. vaginalis could
have a role in colonisation or maintenance of Trichomonas infection by inhibiting the growth
of competing genital bacteria or by modulating the innate immune response.
Higher rate of arginine metabolism in T. foetus
T. foetus showed increased levels of citrulline and ornithine in cell extracts and higher levels of
putrescine were found in spent media suggesting increased flux through the arginine dihydrolase
pathway. Conversion of citrulline to ornithine generates carbamoyl phosphate which is further
catabolised to produce ATP by substrate level phosphorylation, so arginine catabolism could
increase the ATP producing capacity in the cell. This may represent a significant contribution to
energy production because the rate of arginine catabolism, measured by quantifying ammonia
production, was found to be comparable to the rate of carbohydrate catabolism [31]. Arginine
deiminase (ADI), the first enzyme of the pathway catalysing the formation of urea and citrulline
from arginine, was recently found to be located in the hydrogenosome whereas all other enzymes
in the pathway are cytoplasmic [80]. The significance of the sub-cellular localisation of ADI is
not known but it has been suggested that ammonium ions released by arginine catabolism could
be important for maintenance of hydrogenosomal pH [80]. Alternatively, concentration of argi-
nine in the hydrogenosome could result in increased ADI activity and higher flux. Although lev-
els of intermediates in the arginine dihydrolase pathway were lower in T. vaginalis, other
products of arginine metabolism such as 4-guanidinobutanoate were present at higher levels,
suggesting that deamination or transamination of arginine may be more active in T. vaginalis.
Conclusions
Although the metabolic profiles of T. vaginalis and T. foetus are overall very similar, this study
has identified a number of polar metabolites that differ significantly in relative abundance.
Metabolomic profiling of Trichomonas vaginalis and Tritrichomonas foetus
PLOS ONE | https://doi.org/10.1371/journal.pone.0189072 December 21, 2017 27 / 34
Our study indicates that MGL efficiently removes homocysteine in T. vaginalis and hence
maintains low levels of SAH. This is important because SAH is an inhibitor of SAM-dependent
methyltransferases responsible for the methylation of nucleic acids, proteins and lipids. In
addition, CH3SH released from methionine by MGL is used by the T. vaginalis CS to produce
SMC, and we proposed that this has a role along with cysteine as an intracellular antioxidant.
CS has been investigated as a chemotherapeutic target in other organisms [81]. T. vaginalis
and T. foetus are microaerophiles, they are exposed to oxygen in their natural environment
and antioxidant defence mechanisms are vitally important to protect against oxidative stress.
T. foetus does not produce SMC but maintains much higher intracellular levels of cysteine and
appears to remove homocysteine by conversion to cystathionine. These trichomonads do not
produce reactive oxygen species by aerobic respiration and the low oxygen concentrations
mean that they can tolerate relatively high intracellular concentrations of cysteine [20]. The
reactivity of cysteine in transition-metal autoxidation may be important in controlling oxygen
levels and protecting hydrogenosomal enzymes from inactivation. T. vaginalis and T. foetus
have evolved similar mechanisms for redox homeostasis in a low oxygen environment with
some species-specific adaptations. It is thought that T. vaginalis acquired MGL by lateral gene
transfer and previous biochemical studies failed to detect MGL activity in T. foetus. However,
the recently completed draft genome sequence of T. foetus indicates that the parasite contains
4 isoforms of a putative MGL. Further studies are needed to determine the function that these
putative MGL perform in T. foetus, but the differences in methionine metabolism between the
species observed in this study suggest that it must differ from that of the T. vaginalis enzyme.
The broad specificity T. vaginalis LDH was most likely derived from MDH by gene duplication
and mutation and we confirm that LDH is not present in the T. foetus genome. In addition to
producing lactate as an end product of energy metabolism, we show that T. vaginalis differs
from T. foetus in producing markedly higher levels of the 2-hydroxy acid derivatives of certain
amino acids. HICA, the hydroxy acid derived from leucine is also produced by lactic acid bac-
teria and has antibacterial and antibiotic properties. Early in infection, T. vaginalis must com-
pete with the normal vaginal flora for nutrients and survive exposure to H2O2, produced by
the endogenous lactobacilli. Huang and co-workers used glucose restriction to model these
early conditions and observed an adaptive response that enhanced survival and increased
resistance to H2O2 [47]. Under these conditions, RNAseq revealed a significant up-regulation
of branch-chain aminotransferase and LDH expression [47] required for production of HICA.
Although there was no increase in CS mRNA levels, increased expression of genes for OPS bio-
synthesis were observed. The Km of CS for OPS is relatively high [19], thus increased phospho-
serine availability could result in higher cysteine and SMC levels. Production of SMC and the
release of HICA acid and other hydroxy acids by T. vaginalis could be involved in the changes
in the vaginal microbiome observed during infection and may be beneficial in promoting the
parasite’s survival and proliferation.
Supporting information
S1 Table. Metabolites confirmed by matching retention times with authentic standards or
by MS2 analysis.
(XLSX)
S2 Table. All metabolites identified in cell extracts of T. vaginalis and T. foetus including
confirmed metabolites and putative metabolites identified by accurate mass and predicted
retention time.
(XLSX)
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S3 Table. All metabolites identified in media samples.
(XLSX)
S4 Table. Concentration (μmol/108 cells) of amino acids in cell extracts.
(XLSX)
S5 Table. Concentration (μM) of amino acids in media samples.
(XLSX)
S6 Table. Genes for cysteine, methionine and 2-hydroxy acid metabolism found in the
draft genome of T. foetus and T. vaginalis.
(XLSX)
S1 Fig. 13C labelling of intermediates in central carbon metabolism in T. vaginalis and T.
foetus. T. vaginalis and T. foetus were grown for 20 h at 37˚C in MDM containing 100% D-
[U-13C6] glucose as the only carbohydrate carbon source and cell extracts were analysed by
LCMS. Heat maps of the percentage of unlabelled metabolites and isotopologues with increas-
ing number of 13C atoms are shown for (A) T. vaginalis and (B) T. foetus. Numbers on the heat
map refer to percentage labelling values.
(TIF)
S2 Fig. 13C labelling of intermediates in nucleotide metabolism in T. vaginalis and T. foe-
tus. Heat maps of the percentage of unlabelled metabolites and isotopologues with increasing
number of 13C atoms are shown for (A) T. vaginalis and (B) T. foetus.
(TIF)
S3 Fig. 13C labelling of intermediates in methionine metabolism in T. vaginalis and T. foe-
tus. Heat maps of the percentage of unlabelled metabolites and their isotopologues with
increasing numbers of 13C atoms are shown for (A) T. vaginalis and (B) T. foetus.
(TIF)
S4 Fig. Identification of S-methyl-cysteine in T. vaginalis by MS2. A metabolite with pre-
dicted formula C4H9NO2S was analysed by MS2. The full length molecule was not seen in the
mass spectrum. Fragments detected and their predicted formula are shown (A) in the mass
spectrum and (B) in the table. The data is consistent with the structure of S-methyl-cysteine
(C).
(TIF)
S5 Fig. Multiple sequence alignment of putative MDH genes from T. foetus. Four
putative isoforms of T. foetus MDH are aligned with MDH (TVAG_253650) and LDH
(TVAG_49988). Conserved residues are in white type on a black background. Conservative
amino acid differences are in white type on a grey background. The red arrow below the line
indicates a residue found to be a major determinant of substrate specificity, this is arginine
in T. vaginalis MDH but leucine in T. vaginalis LDH. All isoforms found in T. foetus have a
positively charged residues at this position and are therefore predicted to have MDH
activity. Black arrows indicate conserved residues involved in substrate binding or enzyme
activity.
(TIF)
S6 Fig. Multiple sequence alignment of putative MGL genes from T. foetus and T. vaginalis.
Sequences obtained by tblastn search of the T. foetus and T. vaginalis genome sequences with
the T. vaginalis MGL1 (TVAG_041600) as a query sequence. Conserved residues are in white
type on a black background. Conservative amino acid differences are in white type on a grey
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background. Symbols:▲, active site residues involved in PLP binding;▲, cysteine residue
implicated in methionine binding.
(TIF)
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